Literature DB >> 30743154

Neural correlates of distinct cognitive phenotypes in early Parkinson's disease.

Ece Bayram1, Brent Bluett2, Xiaowei Zhuang3, Dietmar Cordes3, Denise R LaBelle3, Sarah J Banks4.   

Abstract

OBJECTIVE: Cognitive decline is common in Parkinson's disease (PD), but changes can occur in a variety of cognitive domains. The lack of a single cognitive phenotype complicates diagnosis and tracking. In an earlier study we used a data-driven approach to identify distinct cognitive phenotypes of early PD. Here we identify the morphometric brain differences between those different phenotypes compared with cognitively normal PD participants.
METHODS: Six different cognitive classes were included (Weak, Typical, Weak-Visuospatial/Strong-Memory, Weak-Visuospatial, Amnestic, Strong). Structural differences between each class and the Typical class were assessed by deformation-based morphometry.
RESULTS: The different groups evidenced different patterns of atrophy. Weak class had frontotemporal and insular atrophy; Weak-Visuospatial/Strong-Memory class had frontotemporal, insular, parietal, and putamen atrophy; Weak-Visuospatial class had Rolandic operculum; Amnestic class had left frontotemporal, occipital, parietal and insular atrophy when compared to the Typical class. The Strong class did not have any atrophy but had significant differences in left temporal cortex in comparison to the Typical class.
CONCLUSIONS: Structural neuroimaging differences are evident in PD patients with distinct cognitive phenotypes even very early in the disease process prior to the emergence of frank cognitive impairment. Future studies will elucidate whether these have prognostic value in identifying trajectories toward dementia, or if they represent groups sensitive to different treatments.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrophy; Cluster analysis; Cognitive dysfunction; Magnetic resonance imaging; Neuroimaging; Parkinson's disease

Mesh:

Year:  2019        PMID: 30743154      PMCID: PMC6436969          DOI: 10.1016/j.jns.2019.02.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  39 in total

1.  Deformation-based morphometry and its relation to conventional volumetry of brain lateral ventricles in MRI.

Authors:  C Gaser; I Nenadic; B R Buchsbaum; E A Hazlett; M S Buchsbaum
Journal:  Neuroimage       Date:  2001-06       Impact factor: 6.556

2.  Structural connectivity for visuospatial attention: significance of ventral pathways.

Authors:  Roza M Umarova; Dorothee Saur; Susanne Schnell; Christoph P Kaller; Magnus-Sebastian Vry; Volkmar Glauche; Michel Rijntjes; Jürgen Hennig; Valerij Kiselev; Cornelius Weiller
Journal:  Cereb Cortex       Date:  2010-01       Impact factor: 5.357

3.  The neural correlates of human working memory for haptically explored object orientations.

Authors:  Amanda L Kaas; Hanneke van Mier; Rainer Goebel
Journal:  Cereb Cortex       Date:  2006-09-11       Impact factor: 5.357

Review 4.  Imaging cognition II: An empirical review of 275 PET and fMRI studies.

Authors:  R Cabeza; L Nyberg
Journal:  J Cogn Neurosci       Date:  2000-01       Impact factor: 3.225

5.  Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.

Authors:  Carme Junqué; Blanca Ramírez-Ruiz; Eduardo Tolosa; Christopher Summerfield; María-José Martí; Pau Pastor; Beatriz Gómez-Ansón; José Ma Mercader
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

Review 6.  Dementia in Parkinson's disease.

Authors:  Dag Aarsland; Mona K Beyer; Martin W Kurz
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

7.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Authors:  Mona K Beyer; Jan P Larsen; Dag Aarsland
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

8.  Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

Authors:  Thomas P Bouchard; Nikolai Malykhin; W R Wayne Martin; Christopher C Hanstock; Derek J Emery; Nancy J Fisher; Richard M Camicioli
Journal:  Neurobiol Aging       Date:  2007-03-26       Impact factor: 4.673

9.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

10.  Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease.

Authors:  Joana B Pereira; Carme Junqué; María-Jośe Martí; Blanca Ramirez-Ruiz; Nuria Bargalló; Eduardo Tolosa
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

View more
  4 in total

1.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

Review 2.  Sleep Disorders and Cognitive Dysfunctions in Parkinson's Disease: A Meta-Analytic Study.

Authors:  Gianpaolo Maggi; Luigi Trojano; Paolo Barone; Gabriella Santangelo
Journal:  Neuropsychol Rev       Date:  2021-03-29       Impact factor: 7.444

3.  The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.

Authors:  Lihua Li; Bingjun Ji; Ting Zhao; Xuan Cui; Jingtao Chen; Zhenyu Wang
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

4.  Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson's Disease.

Authors:  Quentin Devignes; Romain Viard; Nacim Betrouni; Guillaume Carey; Gregory Kuchcinski; Luc Defebvre; Albert F G Leentjens; Renaud Lopes; Kathy Dujardin
Journal:  Front Aging Neurosci       Date:  2021-05-13       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.